5.28
5.28 (-0.01%)
As of Apr 26, 2021
Nuwellis, Inc. [CHFS]
Source:
Company Overview
Nuwellis, Inc. is a commercial-stage medical technology company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovative technology. The company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems.
| Country | United States |
| Headquarters | eden prairie, minnesota |
| Phone Number | 952-345-4200 |
| Industry | manufacturing |
| CEO | John L. Erb* |
| Website | www.nuwellis.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $8.7 |
| Operating Profit | $-11 |
| Net Income | $-11.2 |
| Net Cash | $1.3 |
Profit Ratios
| Gross Margin | $5.7 |
| Operating Margin | -125.7 |
| Profit as % of Revenues | -50.8% |
| Profit as % of Assets | -113.7% |
| Profit as % of Stockholder Equity | -171% |
Management Effectiveness
| Return on Equity | -171% |
| Return on Assets | -113.2% |
| Turnover Ratio | 89% |
| EBITA | $-11 |
Balance Sheet and Cash Flow Measures
| Total Assets | $9.9 |
| Total Liabilities | $3.3 |
| Operating Cash Flow | $-9.6 |
| Investing Cash Flow | $-0.1 |
| Financing Cash Flow | $11 |
